News Snapshot:
NEW DELHI (REUTERS) - India has found 26 suspected cases of bleeding and clotting among recipients of the AstraZeneca vaccine, the health ministry said on Monday (May 17), describing the risk as "minuscule" out of the 164 million doses administered. Some countries have suspended or restricted use of the shot over fears of possible side effects, though health experts have said its benefits outweigh the risks. This is the first time India has reported any serious reaction to the use of the vaccine, branded locally as Covishield. India's adverse events committee reviewed 498 instances of serious and severe side effects...
